CDER schedules third workshop for patient advocacy groups

FDA’s Center for Drug Evaluation and Research will hold a public workshop on April 3 on how to engage effectively with the center. The workshop, entitled “CDER and You: Keys to Effective Engagement,” will feature an interactive panel of patient advocates who will offer engagement guidance. The meeting will also highlight a new system FDA launched earlier this month to make it easier for non-industry stakeholders -- such as patient advocacy groups and providers -- to request drug-related meetings with CDER (see BioCentury Extra, Feb. 9)...